SAURFAR IVS: Financial statements 2014
CVR: 35648534
Source: annual report 2014, Danish Business Authority
23/01/2014 – 31/12/2014
SAURFAR IVS (CVR 35648534) has filed annual accounts for 2014. In 2014, the company reported a gross profit of DKK -48,690 and a net result of DKK -48,688. Equity in the 2014 report amounted to DKK -46,688.
- Gross Profit
- DKK -48,690
- Profit/Loss
- DKK -48,688
- Equity
- DKK -46,688
- Total Assets
- DKK 1,253
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2014
On June 24, 2014, the company changed its name from PROFEKTA IVS to QASHFLOW IVS.
On April 9, 2014, the company changed its name from MELLERGAARD & TERKELSEN IVS to PROFEKTA IVS.
As of April 8, 2014, Mads Mellergaard Baldersø is registered as adm. dir of SAURFAR IVS.
As of April 8, 2014, Rasmus Terkelsen has stepped down as adm. dir of SAURFAR IVS.
On February 18, 2014, the company changed its name from EUROPEAN COMPANY REGISTER IVS to MELLERGAARD & TERKELSEN IVS.
As of January 23, 2014, Rasmus Terkelsen is registered as adm. dir of SAURFAR IVS.
SAURFAR IVS was founded on January 23, 2014.
About SAURFAR IVS
SAURFAR IVS was a Danish company of the type Iværksætterselskab based in Lundby, founded in 2014. The company has been dissolved on 13 October 2021. The company was registered under the industry Detailhandel med andre varer i.a.n. via internet. The company was previously named QASHFLOW IVS and PROFEKTA IVS. In 2019, the company reported revenue of DKK 33,000 and a net result of DKK -3,223 compared with DKK -555 the year before. Equity in the 2019 report amounted to DKK -261,131.